Clinical Trial Update: Safety and Efficacy Dose of Artesunate Used in Combination With LAPDAP Treatment of Uncomplicated Falciparum Malaria [Phase 2]

View source ↗

Summary

This Phase 2 trial reports safety and efficacy data for artesunate used in combination with LAPDAP to treat uncomplicated Plasmodium falciparum malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria

Drugs mentioned

• Artesunate (artesunate)
• Lapdap (chlorproguanil-dapsone)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Malaria | Phase 2 | Status: COMPLETED